Pierre Fabre CDMO has announced it will be presenting its innovative SuperCritical CO2 technology during CPhI US & North America 2018.
The company will be present at booth #357 from 24 April to 26 April at the Pennsylvania Convention Center, Philadelphia. Pierre Fabre CDMO’s Supercritical fluids project manager Hubert Lochard will welcome you to the booth.
Pierre Fabre CDMO will present its expertise in SuperCritical CO2 technology for:
• Pre-formulation of active pharmaceutical ingredients (API)
• Purification of injectable polymer, including polylactic acid (PLA), polylactic-co-glycolic acid (PLGA) and poloxamer
• Cleaning / treatment of medical components
The Supercritical Fluids Division also provides current good manufacturing practice (cGMP) custom manufacturing in extraction and purification.